Since June 2022, Bob has undergone two interventional radioembolizations and many drip immunotherapy treatments, which killed 90% of the cancer and temporarily improved liver function. However, his stimulated immune system caused multiple adverse events, resulting in acute kidney injury and anemia. These conditions prevent him from continuing liver cancer treatment, potentially leading to cancer growth and metastasis.
